socalTECH

NOVEMBER 4, 2009

For this morning's interview, we sat down with Dr. Alfred Wong , Chief Science Officer, and Albert Liu , Vice President of Business Development, at Pong Research (www.pongresearch.com), a company developing products for redirecting cell phone antennas to reduce the radiation exposure of users. Talk about the technology behind the product?

Research 138

Research UCLA Design Product 138

socalTECH

MARCH 8, 2011

San Diego-based Sapphire Energy , a developer of algae-based biofuels technology, has scored an investment and deal with agricultural chemicals firm Monsanto , the two said this morning. Monsanto said it would make an un-specified equity investment in Sapphire, and the two will collaborate on algae-based research projects.

San Diego 145

San Diego Equity Research Invest 145

Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43

Xconomy

JUNE 22, 2016

Agtech investment firm Finistere Ventures; private equity firm Cloud Break Advisors; and Israeli venture capital firm OurCrowd contributed to the new accelerator. Radicle representatives plan to discuss their plans for the accelerator during AgTech Week 2016 , an ag investment conference being held in San Francisco this week.

Funding 68

Funding Research San Diego Incubator 68

Xconomy

JUNE 28, 2018

The Series D round included investments from previous BitSight backers Menlo Ventures, GGV Capital, and Singtel Innov8. The Series D round included investments from previous BitSight backers Menlo Ventures, GGV Capital, and Singtel Innov8. The new funding brings BitSight’s total venture capital haul to $155.

Venture Capital 55

Venture Capital Equity Research Capital 55

socalTECH

DECEMBER 26, 2018

In my new role as the first executive director for the Alliance for Southern California Innovation, I spent a lot of time outside of my home turf of Pasadena -- visiting innovation nodes such as San Diego, Irvine, Riverside, Santa Barbara, Venice, Santa Monica, and others.

Southern California 113

Southern California SoCal Pasadena Startup 113

Xconomy

JANUARY 7, 2020

Eventually Celgene kicked in $35 million more for a research collaboration, an equity stake, and an exclusive option to acquire the startup, PharmAkea Therapeutics.

Seed Funding 63

Seed Funding Equity Research Acquisition 63

socalTECH

JUNE 21, 2013

Instead of equity, the company is aimed at profiting profitable small businesses with business debt funding from investors, to help those businesses grow and get to the next level. Why did you decide to focus on debt, not equity? Ethan Senturia: There are a number of things, including my background.

Startup 247

Startup Software Review Entrepreneur Equity 247

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. 25 that it had uncovered “troubling cybersecurity flaws” in St.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

OCTOBER 12, 2016

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry. billion , according to ArcView Market Research. The ArcView Group is a partner in CanopyBoulder).

San Diego 40

San Diego Startup Southern California Invest 40

Xconomy

JUNE 26, 2018

But that is starting to change, as Asian cities—particularly in China—are snapping up more tech venture capital funding and exits, according to a new report from CB Insights. But Beijing and Shanghai startups appear to be working to keep pace, reeling in $72.

Startup 84

Startup Report Venture Capital Research 84

Xconomy

JULY 22, 2016

It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment. And on the West coast, Palo Alto, CA-based Bioz started up with $3 million in seed cash from 5AM Ventures to help develop software meant to help speed up life sciences research.

Startup 40

Startup San Diego News Thousand Oaks 40

Xconomy

SEPTEMBER 19, 2016

For the life sciences industry, one of the largest landlords, and closest observers, is Alexandria Real Estate Equities. from San Francisco, San Diego, and Seattle on the west coast to Boston, New York, and Research Triangle Park out east. Lately, Alexandria is aggressively expanding its reach. What do you see?

Venture Capital 40

Venture Capital Startup San Diego Class 40

Xconomy

MAY 30, 2016

What, I think, is the first technology-based, early-stage venture capital fund anywhere, American Research and Development , was founded between Georges Doriot at Harvard Business School and Karl Compton, who was president of MIT at the time. Twenty years ago, everybody in Boston knew he was.

Startup 67

Startup Compton Research Technology 67

Xconomy

NOVEMBER 21, 2016

IPO activity at a sluggish pace—so sluggish, in fact, that this year could end with the fewest IPOs and the lowest level of capital raised since 2009, according to PitchBook data for the first nine months of 2016. The institutional research firm is predicting a surge of IPOs in the weeks and months to come.

Research 40

Research Activity Capital Funding 40

Xconomy

JUNE 3, 2016

billion acquisition of San Diego’s Auspex Pharmaceuticals last year. —Edison, NJ-based Contravir Pharmaceuticals (NASDAQ: CTVR ) acquired privately held Ciclofilin Pharmaceuticals of San Diego to add another experimental drug for hepatitis B to its portfolio. Teva nabbed deutetrabenazine in its $3.2

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

NOVEMBER 30, 2018

A Chinese researcher, He Jiankui, claimed he helped bring to life two genetically engineered babies, twin girls with a gene disabled to make them immune to HIV infection. This was one of those weeks when the world seemed to slip into a new era with no going back.

Research 70

Research Help Technology Venture Capital 70

socalTECH

MARCH 31, 2014

He ran DARPA research out of UC Irvine for almost a decade, until stepping out and focusing purely on entrepreneurial efforts. To give you an overview, there are something like 6,000 equities in the U.S. It wouldn''t be covered in the Los Angeles Times, and not by the San Diego papers. We''re using state of the art tools.

Orange County 245

Orange County Startup News IBM 245

Xconomy

SEPTEMBER 21, 2016

We’d like to thank the launch sponsors/underwriters who have joined us to support this new channel: Alexandria Real Estate Equities, Michigan State University, the North Carolina Biotechnology Center, and Spensa Technologies. and Cybersecurity. Xconomy editors around our network will be contributing to the new channel.

Newsletter 40

Newsletter Research Technology Equity 40

Xconomy

FEBRUARY 28, 2018

A core element in this universe is the invention of new kinds of credentials that attest to an independent learner’s mastery of skills that are in demand by employers, such as coding, critical thinking, and even physical tasks such as research laboratory techniques. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Education 45

Education Report Demand Research 45

Xconomy

JUNE 14, 2019

Is one of the bigger biopharma acquisitions of the year in trouble? This past week, antitrust regulators once again delayed Roche’s planned $4.8 billion buyout of gene therapy developer Spark Therapeutics (NASDAQ: ONCE ).

News 97

News Competition Acquisition Report 97

Xconomy

MAY 17, 2019

Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. But such tools only work when companies play fair.

Pricing 79

Pricing Competition Tool Marketing 79